Related content

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma

By                          

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 381-386

Spandidos Publications

Access to resources Recommend Favorite

Radiotherapy combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma — a prospective clinical trial

By Cai Ling  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 64-68

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and adverse events of transcatheter arterial chemoembolization in combination with sorafenib in the treatment of unresectable hepatocellular carcinoma

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 929-935

Science Publishers

Access to resources Recommend Favorite

Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma

By            

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 151-160

Spandidos Publications

Access to resources Recommend Favorite

Three (3) Cases of Advanced HepatocellularCarcinoma (HCC) Treated Successfully by Transcatheter Arterial Chemoembolization (TACE) Using Lipiodol and a Fine Powder Formulated Cisplatin (DDPH)

By Kasai Kazuhiro   Kuroda Hidekatsu   Ushio Akira   Miyamoto Yasuhiro   Sawara Kei   Miyasaka Aikio   Takikawa Yasuhiro   Suzuki Kazuyuki  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 479-483

Sunmedia

Access to resources Recommend Favorite